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months of AICC infused prophylaxis (PX) with 6 months of on-demand (OD) ther-
apy, separated by a 3-month washout period during which patients used on-de-
mand therapy. HRQoL was summarized in two continuous variables: Physical
Component Score (PCS-36) and Mental Component Score (MCS-36). The difference
between two study periods for 6-month change from baseline in PCS-/MCS-36 are
compared using Wilcoxon signed-rank test to measure the difference between two
groups regardless of the sequence of medications. To investigate the effect of ran-
dom sequence in the change of HRQoL, the difference between two study periods
for 6-month change from baseline in PCS-/MCS-36 is compared by random se-
quence using Wilcoxon-Mann-Whitney U test with exact statement. RESULTS:
Twenty-six patients completed both study periods. 17 of them were 14 years old
and thus completed QoL questionnaires and are included in this analysis. The
difference between PX and OD in 6-month change from baseline was 2.83 for
PCS-36 (p0.378) and 1.29 for MCS-36 (p0.890), favored PX on both measures.
Regardless of random sequence of medication, HRQoL showed a moderate im-
provement with PX. When comparing the difference of 6-month change by treat-
ment sequence, patients who initiated with PX then switched to OD had a greater
improvement compared to the opposite sequence (PX-OD: 6.59, OD-PX: 0.19 for
PCS-36 (p0.475); PX¡OD: 2.66, OD¡PX: 0.33 for MCS-36 (p0.601)).
CONCLUSIONS: A cross-over effect, albeit statistically non-significant, was ob-
served when the difference of 6-month change was compared by treatment se-
quence. Patients who started with more favorable medication tended to show a
greater improvement, whereas patients in opposite sequence showed a slight im-
provement.
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OBJECTIVES: Russian Society of Pharmacoeconomics and Outcomes Research
jointly to Russian Hemophilia Society carried out postal and telephone health sur-
vey of all known Russian patients with hemophilia in the period 2009-2010. Aim of
the study was to assess health status, treatment patterns and quality of life in
patients with inhibitory form of hemophilia. METHODS: Postal and telephone
health survey. The questionnaire contained questions on clotting factor level and
presence of antibodies to it, names of used medications. Health-related quality of
life was assessed with self-administrated validated version of Russian version of
Euroqol-5D questionnaire, comprising a dimensions of health and visual-analog
scale. Statistical analysis of data was performed with 2 criteria. RESULTS: The
results of principal methods of treating inhibitory form of hemophilia in 60 patients
with haemophilia A were analysed. Health-related quality of life was assessed for
patients older than 11 years (n 56). More than half of patients reported problems
within each of EQ-5D dimensions of health. Thus 76.6% of patients reported of
problems with mobility; 48.4% of patients informed of difficulties with self-care;
75% of patients had difficulties with usual activity; 81.7% of patients reported of
presence of pain or discomfort; 50.1% of patients had an anxiety or depression. The
average value of quality of life evaluated with visual-analog scale (VAS) was 0.57
(SD 0.17), median – 0.52.CONCLUSIONS: The study of quality of life in patients with
hereditary coagulopathies was performed for the first time in Russian. Results of
the study shown high rate of pain/discomfort, of problems with movement, usual
activity and low rate of problem with self-care and anxiety/depression.
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OBJECTIVES: To assess the quality of life in patients suffering from intense pain
which has progressed since less than 7 days treated by a combination of paraceta-
mol and codeine. METHODS: A multi-centre longitudinal observational prospec-
tive study carried out in metropolitan France using data collected by general prac-
titioners who agreed to participate. RESULTS: A total of 804 patients treated by a
paracetamol-codeine combination (600mg/50mg and 400mg/20mg) were included;
at inclusion the quality of life assessed using SF-12 was affected as much in terms
of the mental component (41.4 11.6) as the physical component (35.4 8.04) – the
norm of the scores for each component is equal to 50 – on D7, the quality of life
assessed in a similar manner using SF-12 was 43.31  9.89 for the mental compo-
nent and 40.93  7.92 for the physical component. A statistically significant im-
provement was noted for each of the 2 mental (p0.001) and physical (p0.001)
components between the first day of treatment and the seventh day. On D7, 95.9%
declared treatment to be effective, 87.2% were satisfied with their treatment and
89.2% did not observe any side effects to the treatment. 9 out of 10 patients did not
complain about side effects related to the treatment.CONCLUSIONS:The improve-
ment in quality of life observed directly through SF-12 was also confirmed by pa-
tient satisfaction: from the first day, 61% of patients declared themselves to be
satisfied. On the 7th day of treatment, 87.10% were satisfied with their treatment.
2/3 patients declared the treatment to be effective from the 1st day, and 91% of
them declared this on the 3rd day: It shows the pertinence of the treatment.
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OBJECTIVES: A daily assessment of the speed of action and effectiveness of treat-
ment of a combination of paracetamol and codeine in patients suffering from
intense pain, which has progressed since less than 7 days. METHODS: A multi-
centre longitudinal observational prospective study carried out in metropolitan
France using data collected by general practitioners who agreed to participate.
RESULTS: A total of 804 patients treated by a paracetamol-codeine combination
(600mg/50mg and 400mg/20mg) were included. The severity of pain measured at
inclusion using a visual numeric scale was 7  1.3. The severity of pain measured
after half a day of treatment was 5.29 1.87 and 5.65 1.85 at the end of the first 24
hours of treatment. A significant improvement in pain was observed from the first
half-day (p0.001). The severity of pain on the 2nd, 4th and 7th evenings was
respectively 4.09 1.87; 2.74 1.8 and 1.78 1.7. On D1, 70.8% declared treatment
to be effective, 62.56% were satisfied with their treatment and 80.5% did not ob-
serve any side effects to the treatment. On D3, 91.5% declared treatment to be
effective, 82.4% were satisfied with their treatment and 83.12% did not observe any
side effects to the treatment. On D7, 95.9% declared treatment to be effective, 87.2%
were satisfied with their treatment and 89.2% did not observe any side effects to the
treatment. 9 out of 10 patients did not complain about side effects related to the
treatment.CONCLUSIONS:A reduction in pain within the first 12 hours showed the
pertinence of treatment using a paracetamol-codeine combination. This perti-
nence was confirmed by 2/3 patients who declared the treatment to be effective
from the 1st day, and 91% of them declared this on the 3rd day.
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OBJECTIVES: Russian Society of Pharmacoeconomics and Outcomes Research
jointly to Russian Hemophilia Society carried out postal and telephone health sur-
vey of all known Russian patients with inhibitor hemophilia in the period 2009-
2010. Aim of the study was to assess health status, treatment patterns and quality
of life in patients with inhibitory form of hemophilia. METHODS: Postal and tele-
phone health survey. The questionnaire contained questions on clotting factor
level and presence of antibodies to it, number of bleeding in last month, number of
injections of clotting factors per month, names of used medications, ways of re-
ceiving medications, number of ambulance calls and hospitalizations, and the way
of administration of medicines. The patients’ education level and employment
data was collected. Analysis of experimental data was performed with such statis-
tical parameters as 2 and Student’s criteria. RESULTS: The presence of antibodies
was detected in 60 patients with haemophilia A (47 patients (78.3%) were adults, 4
(6.7%) – adolescents, 9 (15%) - children upward 11 years old). Mean age was 30 years.
90% of patients experienced bleeding in the last month (median – 3). 85% of patients
used clotting factor VIII in the last month (median – 12 times). 13.3% of patients
called for an ambulance in a last month and 21.7% of patients were hospitalized
during last month. 68.3% of patients perform the injections of clotting factor
themselves. CONCLUSIONS: The study revealed epidemiologic characteristics and
treatment patterns of inhibitor hemophilia in Russia.
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OBJECTIVES: Russian Society of Pharmacoeconomics and Outcomes Research
jointly to Russian Hemophilia Society carried out postal and telephone health sur-
vey of all known Russian patients with hemophilia in the period 2009-2010. Aim of
the study was to assess health status, treatment patterns and quality of life in
patients with inhibitory form of hemophilia. METHODS: Postal and telephone
health survey. The questionnaire contained questions on number of bleeding in
last month, number of injections of clotting factors per month, names of used
medications, number of ambulance calls and hospitalizations. The patients’ edu-
cation level and employment data was collected. Analysis of experimental data
was performed with such statistical parameters as 2 and Student’s criteria.
RESULTS: The presence of antibodies was detected in 60 patients with hemophilia
A (47 patients (78,3%) were adults, 4 (6,7%) – adolescents, 9 (15%) - children upward
11 years old). All patients were divided into 3 subgroups: 31.7% patients received
immunological tolerance (IIT), 31.7% - therapy with NovoSeven, 36.6% - mixed
therapy. During one month bleeding was indicated in 78.9%, 100%, 90.9% patients
in 3 subgroup respectively; clotting factor VIII was used in 100%, 73.7%, 95.4%
patients respectively; emergency calls were made by 10.5%, 5.3%, 22.7% patients;
26.3%, 31.6%, 13.6% patients were hospitalized; 63.2%, 68.4%, 72.7% patients made
injections of clotting factor themselves. CONCLUSIONS: The rate of ambulance
calls and hospitalizations was comparatively low. Most patients made injections of
clotting factor themselves.
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